Sharafat Hussain: Understanding CD Markers in Modern Cancer Therapy
Sharafat Hussain explains the role of Cluster of Differentiation (CD) markers in oncology, clarifying how these surface proteins serve as targets for precision cancer therapies. The article distinguishes CD markers from other therapeutic targets like HER2 and EGFR.
Why it matters
Understanding these molecular markers is essential for grasping the mechanisms behind modern targeted cancer treatments and immunotherapy.
Sharafat Hussain , Zonal Sales Manager (North) Oncology at Revive Healthcare International, shared a post on LinkedIn :
The content is educational and scientific, focusing on medical definitions.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in